Splenda (Sucralose) Found To Have Diabetes-Promoting Effects

Promoted for decades as a "safe" sugar alternative, presumably to prevent or reduce symptoms of diabetes, Splenda (sucralose) has been found to have diabetes-promoting effects in human subjects.
The artificial sweetener sucralose, which is approximately 600 times sweeter than sucrose (table sugar), and marketed under a variety of brand names, such as Splenda, Cukren, Nevella and SucraPlus, has recently been found to have diabetes-promoting effects in human test subjects, despite containing no calories and being classified as a 'nonutritive sweetener.'
A new study published in the journal Diabetes Care, lead by researchers at the Center for Human Nutrition, Washington University School of Medicine, St. Louis, Missouri, set out to test the metabolic effects of sucralose in obese subjects who did not use nonnutritive sweeteners.
Seventeen subjects underwent a 5-hour oral glucose tolerance test on two separate occasions preceded by consuming either sucralose (experimental condition) or water (control condition) 10 min before the glucose load in a randomized crossover design.
The results were reported as follows:
Compared with the control condition, sucralose ingestion caused 1) a greater incremental increase in peak plasma glucose concentrations (4.2 ± 0.2 vs. 4.8 ± 0.3 mmol/L; P = 0.03), 2) a 20 ± 8% greater incremental increase in insulin area under the curve (AUC) (P < 0.03), 3) a 22 ± 7% greater peak insulin secretion rate (P < 0.02), 4) a 7 ± 4% decrease in insulin clearance (P = 0.04), and 5) a 23 ± 20% decrease in SI (P = 0.01).
In other words, a single dose of suc Continue reading

Rate this article

Total 1 ratings

Diabetes Reflexology Foot Massage

Ads by Google
For over 100 years, massage has been recommended for diabetes. Relaxation from massage has greater than the rest alone. It improves circulation, thus useful for diabetic neuropathy and other complications.
Reflexology is simple to perform self-massage without any side effects. Additionally, it is beneficial in controlling diabetes and has numerous health benefits to your entire body. Reflexology for diabetes helps to lower their medicinal dosage to control blood glucose level.
High glucose causes & how the reflexology helps to relieve it?
High levels of blood glucose are due to defect in carbohydrate or glucose metabolism such as problem with stomach, intestine, liver, pancreas, or muscle cells. You can resolve it by stimulating certain organ reflex points. See the picture for the reflex points of the different organs.
Reflexology diabetes foot massage
Reflexology for diabetes include massaging reflexes of endocrine glands and organs responsible for glucose metabolism & damaged by hyperglycemia.
It is always preferred and advisable to start the reflexology treatment with massaging endocrine glands; which controls the entire bodily function. Then, massage the organs that might cause blood glucose rise. Finally, massage the organs that would be affected due to the high glucose level in blood.
Reflexology massage for Endocrine system
Pituitary gland - It is the master endocrine gland; its hormone controls other endocrine glands such as thyroid, adrenal, and reproductive glands. Endorphins secreted by the pituitary; acts on the nervous system and reduces pain.
Pin Continue reading

Alex Azar, Trump’s HHS Pick, Has Already Been a Disaster for People With Diabetes

Last year The New York Times published an op-ed urging the break up of the “insulin racket.” But rather than break it up, Trump has nominated one of its architects, Alex Azar, for secretary of Health and Human Services.
From 2007 to 2017, Azar worked for pharmaceutical giant Eli Lilly. While he was a senior VP, Lilly paid a record $1.415 billion to settle a case on its off-label promotion of the antipsychotic Zyprexa. Rising up the ranks, Azar became president of Lilly USA, the largest division of Eli Lilly, in 2012, a position he held until resigning in January of this year.
During Azar’s tenure, Eli Lilly raised the prices on its insulins in the United States by 20.8 percent in 2014, 16.9 percent in 2015, and 7.5 percent in 2016. Eli Lilly’s biggest seller, Humalog insulin, is now off-patent. But rather than becoming cheaper, Humalog costs more now than when it first came to market in 1996. When Azar started working at Eli Lilly in June 2007, the list price for a vial of Humalog was $74. When he quit in January 2017, it was $269.
At T1International we asked people with type 1 diabetes around the world how much they paid each month to stay alive. The United States topped every country, spending on average $571.69 per month on diabetes costs. Even with insurance, some Americans are spending around half their income on insulin and other supplies.
In fact, price gouging from Eli Lilly and other insulin manufacturers has already had deadly consequences. Shane Patrick Boyle, a founder of Zine Fest Houston, died on March 18 after his GoFundMe campaign to pay for insulin Continue reading

Broccoli Could Be a Secret Weapon Against Diabetes, Say Scientists

Broccoli contains an ingredient that can help those with type 2 diabetes control their blood sugar level, according to a new study – potentially providing a much-needed treatment option for millions.
A chemical in cruciferous vegetables like broccoli and sprouts called sulforaphane is thought to be responsible, having been shown to lower glucose levels in earlier lab experiments on diabetic rats.
To identify suitable compounds to examine, researchers used computer models to identify gene expression changes linked with type 2 diabetes, and then sift through thousands of chemicals that might reverse these changes.
"We're very excited about the effects we've seen and are eager to bring the extract to patients," one of the researchers, Anders Rosengren of the University of Gothenburg in Sweden, told Andy Coghlan at New Scientist.
"We saw a reduction of glucose of about 10 per cent, which is sufficient to reduce complications in the eyes, kidneys and blood."
That 10 percent average reduction was across a sample of 97 human volunteers taking part in a 12-week randomised, placebo-controlled trial. The participants who were obese and who had higher baseline glucose levels to begin with benefitted the most.
The dose was the equivalent of around 5 kilograms (11 pounds) of broccoli daily – a fair few platefuls – but the researchers say it could be adapted into a powder to add to food or drinks.
It's important to note that all but three of those taking part in the trial continued to take metformin, a drug already used to improve blood sugar regulation in people with diabetes.
How Continue reading

A Modest Dose of Ginger Improves 8 Markers of Diabetes Type 2

A promising new study published in the International Journal of Food Sciences and Nutrition reveals that the popular kitchen spice ginger may be an effective treatment for the prevention of diabetes and its complications.
Ginger is in the same plant family (Zingiberacea) that includes the medicinal powerhouse turmeric, and which only recently was proven to be 100% effective in preventing the development of type 2 diabetes in prediabetics, according to a study published in the American Diabetes Association's own journal Diabetes Care.
In the new ginger study, titled "The effect of ginger consumption of glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus,"[i] 70 type 2 diabetic patients were enrolled in a double-blinded, placebo-controlled clinical trial, the objective of which was to assess the effect of ginger consumption on glycemic status, lipid profile and some common inflammatory markers associated with the condition.
The trial participants were divided randomly into a ginger group and control group, receiving either 1600 mg ginger or a 1600 mg placebo daily for 12 weeks. The patients were measured before and after the intervention for blood sugar levels, blood lipids, C-reactive protein, prostaglandin E2 and tumor necrosis factor alpha (TNFα).
As a result of the intervention, ginger treatment reduced the following parameters significantly compared with the placebo group:
Fasting plasma glucose
HbA1C (aka glycated hemoglobin) - a measurement of how much damage is being caused by sugars to red blood cells in the body, r Continue reading